Yongjun Zhou
Quanzhou, 362000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Effect of dyslipidemia on HBsAg clearance in nucleos(t)ide analogues-experienced chronic hepatitis B patients treated with peginterferon alfa.
Journal: BMC infectious diseases
Published: August 09, 2024
Effect of HBeAg/anti-HBe coexistence on HBeAg seroconversion in treatment-naïve chronic hepatitis B patients with peginterferon-α.
Journal: Therapeutic advances in gastroenterology
Published: June 30, 2024
A simple-to-use score system for predicting HBsAg clearance to peginterferon alfa-2b in nucleoside analogs-experienced chronic hepatitis B patients.
Journal: Frontiers in medicine
Published: June 20, 2023
Epidemiological and clinical features of SARS-CoV-2 Omicron variant infection in Quanzhou, Fujian province: a retrospective study.
Journal: Scientific reports
Published: January 12, 2023
Emergency Decision-making Method of Unconventional Emergencies in Higher Education Based on Intensive Learning.
Journal: Journal of environmental and public health
Published: July 19, 2022
Decreased frequency of a novel T-lymphocyte subset, CD3+ CD4- CD7+ CD57- T cells, in hepatitis B virus-related end-stage liver disease might contribute to disease progression.
Journal: Journal of medical virology
Published: July 07, 2022
Clinical characteristics of patients infected with novel coronavirus wild strain, Delta variant strain and Omicron variant strain in Quanzhou: A real‑world study.
Journal: Experimental and therapeutic medicine
Published: June 11, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026